Literature DB >> 24891006

Elevation of interleukin-6 and attenuation of tumor necrosis factor-α during wheelchair half marathon in athletes with cervical spinal cord injuries.

T Ogawa1, T Nakamura1, M Banno1, Y Sasaki1, Y Umemoto1, K Kouda1, T Kawasaki1, F Tajima1.   

Abstract

STUDY
DESIGN: Nonrandomized study.
OBJECTIVES: The purpose of this study was to determine the effects of long and intensive exercise on interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) in athletes with cervical spinal cord injuries (CSCI).
SETTING: The 30th Oita International Wheelchair Marathon Race.
METHODS: Blood samples from six athletes with CSCI and eight athletes with thoracic and lumber spinal cord injuries (SCI) participating in wheelchair half marathon race were collected before the race, immediately after the race and 2 h after the race. IL-6, TNF-α, adrenaline and blood cell counts were measured.
RESULTS: Monocyte count remained stable throughout the study in the CSCI group but was significantly high at 2 h after the race in the SCI group. Plasma IL-6 concentrations were significantly elevated immediately after the race in both groups, although the levels in CSCI were significantly lower than in the SCI group. Plasma adrenaline was significantly elevated immediately after the race in the SCI group but recovered at 2 h after the race. In contrast, plasma adrenaline did not change in the CSCI group throughout the study and was significantly lower than in the SCI group. Plasma TNF-α did not change throughout the study in the SCI group compared with a significant decrease at 2 h after the race in the CSCI group.
CONCLUSION: Long and intensive exercise increased IL-6 in the CSCI group despite the small muscle mass and lack of sympathetic nervous system. The post-race fall in plasma TNF-α in the CSCI group could be related to the inhibitory effect of rising IL-6 in the presence of normal monocyte count and stable adrenaline level.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24891006     DOI: 10.1038/sc.2014.88

Source DB:  PubMed          Journal:  Spinal Cord        ISSN: 1362-4393            Impact factor:   2.772


  6 in total

1.  The ability of heart rate or perceived exertion to predict oxygen uptake varies across exercise modes in persons with tetraplegia.

Authors:  Jessie R Shea; Barbara L Shay; Kristine C Cowley
Journal:  Spinal Cord       Date:  2021-08-30       Impact factor: 2.772

2.  State of Knowledge on Molecular Adaptations to Exercise in Humans: Historical Perspectives and Future Directions.

Authors:  Kaleen M Lavin; Paul M Coen; Liliana C Baptista; Margaret B Bell; Devin Drummer; Sara A Harper; Manoel E Lixandrão; Jeremy S McAdam; Samia M O'Bryan; Sofhia Ramos; Lisa M Roberts; Rick B Vega; Bret H Goodpaster; Marcas M Bamman; Thomas W Buford
Journal:  Compr Physiol       Date:  2022-03-09       Impact factor: 8.915

3.  Changes in oxidized LDL during a half marathon in athletes with spinal cord injuries.

Authors:  Toshihito Mitsui; Tomoyuki Ito; Yusuke Sasaki; Takashi Kawasaki; Takeshi Nakamura; Yukihide Nishimura; Tatsuru Ibusuki; Yukiharu Higuchi; Sayoko Hosoe; Fumiaki Ito; Fumihiro Tajima
Journal:  Spinal Cord Ser Cases       Date:  2017-05-11

4.  Interleukin-6 Serum Levels Are Elevated in Individuals with Degenerative Cervical Myelopathy and Are Correlated with Symptom Severity.

Authors:  Shengchao Du; Yuan Sun; Bizeng Zhao
Journal:  Med Sci Monit       Date:  2018-10-17

5.  Physiological and Metabolic Responses of Amateur Spinal Cord Injured Wheelchair Racers Participating in a Marathon: A Pilot Observational Study.

Authors:  Henry Prakash Magimairaj; Anand Viswanathan; Selvaraj Samuelkamaleshkumar Mot; Thangavelu Senthilvelkumar
Journal:  Prog Rehabil Med       Date:  2021-10-26

6.  Increased serum levels of brain-derived neurotrophic factor following wheelchair half marathon race in individuals with spinal cord injury.

Authors:  Yukihide Nishimura; Takeshi Nakamura; Yoshi-Ichiro Kamijo; Hideki Arakawa; Yasunori Umemoto; Tokio Kinoshita; Yuta Sakurai; Fumihiro Tajima
Journal:  J Spinal Cord Med       Date:  2020-10-15       Impact factor: 2.040

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.